Impact of augmented renal clearance on enoxaparin therapy in critically ill patients
Egyptian Journal of Anaesthesia · 2017-01 · 33 (1) · 113-117
DOI: 10.1016/j.egja.2016.11.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian Journal of Anaesthesia, online erschienen am 17.05.2019. Verfasst von Hala Ezzat Mohamed Abdel El Naeem und 2 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and aim of the workAugmented renal clearance (ARC) was reported in critically ill patients. ARC was associated with poor patient outcome due to decreased effectiveness of drugs leading to treatment failure. The aim of this study is to find the possible impact of ARC on therapeutic action of enoxaparin measured by anti-factor Xa activity.Patients and methodsFifty critically ill patients receiving enoxaparin prophylactic dose (40 mg/day) were included in the study. Creatinine clearance was measured and patients were divided into two groups: normal kidney function group (group C) and augmented renal clearance group (group A). serum anti-factor Xa was measured at baseline, four hours, 12 h, and 24 h. Both groups were compared regarding demographic data, severity scores, kidney function, and anti-factor Xa activity.ResultsTwenty patients (40%) showed ARC and thirty patients (60%) showed normal kidney function. Creatinine clearance was 214 ± 6 in group A versus 112 ± 11 in group C (P = 0.001). Serum anti-factor Xa levels was similar in the two groups after four hours (0.2 ± 0.07 vs. 0.2 ± 0.05, P = 1). Serum anti-Xa levels were significantly lower in group A compared to group C at 12 and 24 h (0.06 ± 0.03 vs. 0.1 ± 0.04, P = 0.004), (0.01 ± 0.01 vs. 0.05 ± 0.01, P = 0.001) respectively.ConclusionARC patients showed short activity of enoxaparin. This finding draws the attention towards dose adjustment in this type of patients.
Zitieren
APA
Naeem, H. E. M. A. E., Abdelhamid, M. H. E., & Atteya, D. A. M. (2017). Impact of augmented renal clearance on enoxaparin therapy in critically ill patients. Egyptian Journal of Anaesthesia, 33(1), 113-117. https://doi.org/10.1016/j.egja.2016.11.001
Vancouver
Naeem HEMAE, Abdelhamid MHE, Atteya DAM. Impact of augmented renal clearance on enoxaparin therapy in critically ill patients. Egyptian Journal of Anaesthesia. 2017;33(1):113-117. doi:10.1016/j.egja.2016.11.001
BibTeX
@article{Naeem2017,
author = {Naeem, Hala Ezzat Mohamed Abdel El and Abdelhamid, Mona Hossam Eldin and Atteya, Dina Atteya Mohamed},
title = {Impact of augmented renal clearance on enoxaparin therapy in critically ill patients},
journal = {Egyptian Journal of Anaesthesia},
year = {2017},
volume = {33},
number = {1},
pages = {113--117},
doi = {10.1016/j.egja.2016.11.001}
}
EUVIMED